Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of <sup>61</sup>Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging

Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of <sup>61</sup>Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging

<b>Background:</b> While gallium-68 has traditionally dominated PET imaging in oncology, copper radionuclides have sparked interest for their potential applications in nuclear medicine and theranostics. Considering the advantageous physical decay properties of copper-61 compared to those...

Full description

Saved in:
Bibliographic Details
Main Authors: Diana Rodrigues, Alexandra I. Fonseca, Sérgio do Carmo, José Sereno, Ivanna Hrynchak, João N. Moreira, Célia Gomes, Antero Abrunhosa
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmaceuticals
Subjects:
copper-61
radiopharmaceutical
automation
positron emission tomography
prostate cancer
prostate specific membrane antigen
Online Access:https://www.mdpi.com/1424-8247/18/4/469
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/4/469

Similar Items